Comparison of quetiapine, olanzapine, and risperidone in schizophrenia

被引：4
|
作者：
Sacchetti, E
Valsecchi, P
Regini, C
Galluzzo, A
Cacciani, P
Agrimi, E
Mencacci, C
机构：
[1] Univ Brescia, Sch Med, Chair Psychiat, I-25121 Brescia, Italy
[2] Univ Brescia, Spedali Civili, Psychiat Unit, I-25121 Brescia, Italy
[3] Brescia Spedali Civili, Dept Mental Hlth, Brescia, Italy
[4] Azienda Osped, Ist Ospitalieri Cremona, Dept Mental Hlth, Cremona, Italy
[5] Osped Fatebenefratelli & Oftalm Milan, Dept Mental Hlth, Milan, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80342-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [1] The comparison of risperidone, olanzapine and quetiapine in the treatment of chronic schizophrenia and schizoaffective disorder
    Kim, JG
    Cho, DH
    Choi, HK
    Kim, HJ
    Cho, JH
    Kang, SH
    Lee, SJ
    Lee, JG
    Kim, HT
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S245 - S245
  • [2] Comparison of quetiapine ('Seroquel'), olanzapine, and risperidone in a randomized study in patients with schizophrenia
    Sacchetti, E
    Valseechi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S413 - S413
  • [3] Antipsychotic monotherapy with olanzapine, risperidone, and quetiapine in the treatment of schizophrenia.
    Faries, D
    Zhu, BJ
    Jiang, Q
    Ascher-Svanum, H
    [J]. PHARMACOTHERAPY, 2003, 23 (10): : 1359 - 1360
  • [4] Schizophrenia: risperidone and olanzapine increase time to discontinuation compared with quetiapine and ziprasidone
    Carpenter, William T.
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2006, 9 (04) : 106 - 106
  • [5] Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: Interim results of a randomised, rater-blinded study
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 150 - 150
  • [6] Comparison of quetiapine, olanzapine and risperidone in patients with schizophrenia: Interim results of a randomised, rater-blinded study
    Sacchetti, E
    Valsecchi, P
    Regini, C
    Galluzzo, A
    Cacciani, P
    Agrimi, E
    Mencacci, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S350 - S351
  • [7] A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
    Woodward, ND
    Purdon, SE
    Meltzer, HY
    Zald, DH
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (03): : 457 - 472
  • [8] A naturalistic comparison of olanzapine and risperidone in children and adolescents with schizophrenia
    De Leon, A
    Lane, DC
    Patel, NC
    Lopez, M
    Crismon, ML
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (04) : 423 - 423
  • [9] Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone
    Larmo, I
    de Nayer, A
    Windhager, E
    Irmansyah
    Lindenbauer, B
    Rittmannsberger, H
    Platz, T
    Jones, AM
    Altman, C
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (08) : 573 - 581
  • [10] Effects of olanzapine, risperidone, quetiapine or haloperidol on quality of life and functional status in patients with schizophrenia
    Huang, Y
    Kim, YH
    Jung, IK
    Habil, H
    Dossenbach, M
    Hodge, A
    McBride, M
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S407 - S408
12345